Adebrelimab - HY-P99422
Nur noch %1 verfügbar
Catalog #
HY-P99422
Ab
310,00 €
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC)[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99422/Adebrelimab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | SHR-1316 |
| CAS | 2247114-85-6 |
| Storage | Store at -80°C for 2 years |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | Phase 4 |
| Target | Apoptosis, PD-1/PD-L1 |
| Application: | Cancer-programmed cell death |
|---|